1. Home
  2. HRMY vs KARO Comparison

HRMY vs KARO Comparison

Compare HRMY & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$31.52

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Karooooo Ltd.

KARO

Karooooo Ltd.

HOLD

Current Price

$47.70

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
KARO
Founded
2017
2001
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
HRMY
KARO
Price
$31.52
$47.70
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$44.11
$59.33
AVG Volume (30 Days)
651.7K
96.5K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
2.52%
EPS Growth
7.97
N/A
EPS
0.55
N/A
Revenue
$868,453,000.00
N/A
Revenue This Year
$19.75
$22.17
Revenue Next Year
$12.88
$16.74
P/E Ratio
$57.36
$24.13
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$41.25
52 Week High
$40.87
$60.95

Technical Indicators

Market Signals
Indicator
HRMY
KARO
Relative Strength Index (RSI) 56.34 47.39
Support Level $25.92 $43.31
Resistance Level $33.11 $47.79
Average True Range (ATR) 0.93 2.32
MACD 0.01 0.06
Stochastic Oscillator 87.38 55.23

Price Performance

Historical Comparison
HRMY
KARO

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About KARO Karooooo Ltd.

Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.

Share on Social Networks: